China Pulled 359 Drugs From Market For Illegal Ads In 2007
This article was originally published in PharmAsia News
A total of 359 drugs were kept off the market by Chinese authorities in the first 10 months of last year because of advertisements deemed illegal. The State FDA said it counted 50,823 illegal ads for medical products during a time when it approved only 16,365. Of the ones approved, it had to recall 122 for various violations such as false or exaggerated assertions. May 2007 was the effective date for a new Measures for the Examination of Drug Advertisements, which allowed government agencies to take action against drug makers for illegal ads. (Click here for more
You may also be interested in...
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
The UK's Celleron has attracted a "blue chip suite of investors" to an Irish-domiciled spin-off based on the potential of Roche-developed emactuzumab for TGCT, a debilitating orphan disease that causes joint damage and has limited clinical options.
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.